Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study.
Schaad UB, Mütterlein R, Goffin H; BV-Child Study Group. Schaad UB, et al. Among authors: mutterlein r. Chest. 2002 Dec;122(6):2042-9. doi: 10.1378/chest.122.6.2042. Chest. 2002. PMID: 12475845 Clinical Trial.
Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
Solèr M, Mütterlein R, Cozma G; Swiss-German OM-85 Study Group. Solèr M, et al. Among authors: mutterlein r. Respiration. 2007;74(1):26-32. doi: 10.1159/000093933. Epub 2006 Jun 12. Respiration. 2007. PMID: 16772707 Clinical Trial.
[A new inhalation system for bronchodilatation. Study of the acceptance of the Ingelheim M inhaler in chronic obstructive respiratory tract diseases].
Mütterlein R, Schmidt G, Fleischer W, Freund E. Mütterlein R, et al. Fortschr Med. 1990 Apr 15;108(11):225-8. Fortschr Med. 1990. PMID: 2141590 Clinical Trial. German.
[New technics for producing inhalation aerosols--initial experiences and results with the piezoelectric inhalation device].
Fischer J, Köhler D, Morr H, Wettengel R, Mütterlein R, Fleischer W, Rauber G, Stechert R. Fischer J, et al. Among authors: mutterlein r. Pneumologie. 1990 Feb;44 Suppl 1:275-6. Pneumologie. 1990. PMID: 2195514 Clinical Trial. German.
Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
Günther G, van Leth F, Altet N, Dedicoat M, Duarte R, Gualano G, Kunst H, Muylle I, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET. Günther G, et al. Int J Tuberc Lung Dis. 2015 Dec;19(12):1524-7. doi: 10.5588/ijtld.15.0274. Int J Tuberc Lung Dis. 2015. PMID: 26614196
Multidrug-resistant tuberculosis in Europe, 2010-2011.
Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET. Günther G, et al. Emerg Infect Dis. 2015 Mar;21(3):409-16. doi: 10.3201/eid2103.141343. Emerg Infect Dis. 2015. PMID: 25693485 Free PMC article.
[Are there any treatment options? Resistance imported from Russia].
Mütterlein R. Mütterlein R. Pharm Unserer Zeit. 2012 Jan;41(1):73-5. doi: 10.1002/pauz.201100455. Pharm Unserer Zeit. 2012. PMID: 22470922 Review. German. No abstract available.
False economies.
Mütterlein R. Mütterlein R. Dtsch Arztebl Int. 2010 Jun;107(24):435; author reply 436. doi: 10.3238/arztebl.2010.0435b. Epub 2010 Jun 18. Dtsch Arztebl Int. 2010. PMID: 20607086 Free PMC article. No abstract available.
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
Migliori GB, Lange C, Centis R, Sotgiu G, Mütterlein R, Hoffmann H, Kliiman K, De Iaco G, Lauria FN, Richardson MD, Spanevello A, Cirillo DM; TBNET Study Group. Migliori GB, et al. Among authors: mutterlein r. Eur Respir J. 2008 Jun;31(6):1155-9. doi: 10.1183/09031936.00028708. Eur Respir J. 2008. PMID: 18515555 Free article.
Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases.
Blaas SH, Mütterlein R, Weig J, Neher A, Salzberger B, Lehn N, Naumann L. Blaas SH, et al. Among authors: mutterlein r. BMC Infect Dis. 2008 May 2;8:60. doi: 10.1186/1471-2334-8-60. BMC Infect Dis. 2008. PMID: 18454863 Free PMC article.
Feedback